ArticleClinical chemistry2014

Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome.

Qing H Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.